We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$400B
AUM Growth
+$29.4B
Cap. Flow
+$10.8B
Cap. Flow %
2.7%
Top 10 Hldgs %
14.74%
Holding
7,051
New
207
Increased
2,867
Reduced
3,206
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Healthcare 9.53%
3 Financials 9.25%
4 Consumer Discretionary 7.98%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMBC
5051
DELISTED
Pacific Mercantile Bancorp
PMBC
$364K ﹤0.01%
38,874
+3,190
+9% +$31.4K
OSG
5052
DELISTED
Overseas Shipholding Group Inc.
OSG
$363K ﹤0.01%
114,950
-17,317
-13% -$60.4K
FWP
5053
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$363K ﹤0.01%
22,763
+3,772
+20% +$73.9K
IMDZ
5054
DELISTED
Immune Design Corp.
IMDZ
$363K ﹤0.01%
105,249
+32,672
+45% +$123K
NAGE
5055
Niagen Bioscience
NAGE
$237M
$362K ﹤0.01%
84,295
-22,211
-21% -$95.5K
AWSM
5056
DELISTED
Cool Holdings Inc. Common Stock
AWSM
$362K ﹤0.01%
32,108
+32,105
+1,070,167% +$164K
MOC
5057
DELISTED
Command Security Corporation
MOC
$362K ﹤0.01%
130,000
-91,100
-41% -$165K
SPTI icon
5058
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
$361K ﹤0.01%
12,402
-3,802
-23% -$111K
UDN icon
5059
Invesco DB US Dollar Index Bearish Fund
UDN
$109M
$361K ﹤0.01%
16,773
-3,516
-17% -$75.8K
EMCB icon
5060
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$98.8M
$360K ﹤0.01%
5,227
-499
-9% -$34.4K
OPP
5061
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$192M
$360K ﹤0.01%
21,465
+3,793
+21% +$65.5K
DMF
5062
DELISTED
BNY Mellon Municipal Income
DMF
$359K ﹤0.01%
45,809
-372
-0.8% -$2.99K
NANR icon
5063
State Street SPDR S&P North American Natural Resources ETF
NANR
$777M
$359K ﹤0.01%
10,455
-5,273
-34% -$183K
PGP
5064
PIMCO Global StockPLUS & Income Fund
PGP
$100M
$358K ﹤0.01%
24,791
+3,079
+14% +$46.4K
VIVS
5065
VivoSim Labs
VIVS
$1.12M
$358K ﹤0.01%
1,298
-171
-12% -$51.4K
BBC icon
5066
Virtus Biotech Clinical Trials ETF
BBC
$49.5M
$357K ﹤0.01%
10,329
-6,586
-39% -$222K
MMV
5067
DELISTED
Eaton Vance Massachusetts Municipal Income Trust
MMV
$357K ﹤0.01%
28,633
+1,433
+5% +$18.1K
NBW
5068
DELISTED
Neuberger Berman California Municipal Fund Inc.
NBW
$355K ﹤0.01%
28,458
-149
-0.5% -$1.88K
DWCH
5069
DELISTED
Datawatch Corp
DWCH
$355K ﹤0.01%
+30,496
New +$367K
CLM icon
5070
Cornerstone Strategic Value Fund
CLM
$2.24B
$353K ﹤0.01%
25,691
+712
+3% +$9.89K
CRNX icon
5071
Crinetics Pharmaceuticals
CRNX
$8.9B
$353K ﹤0.01%
+12,336
New +$366K
DSUM
5072
DELISTED
Invesco Chinese Yuan Dim Sum Bond ETF
DSUM
$353K ﹤0.01%
16,246
-22,971
-59% -$509K
GFN
5073
DELISTED
General Finance Corporation
GFN
$353K ﹤0.01%
22,106
+728
+3% +$10.2K
USDP
5074
DELISTED
USD PARTNERS LP
USDP
$352K ﹤0.01%
36,491
+1,429
+4% +$14.5K
CIB icon
5075
Grupo Cibest SA
CIB
$20.9B
$351K ﹤0.01%
8,412
-22,018
-72% -$989K

Similar funds

Morgan Stanley's Q3 2018 Portfolio in Review

As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
  • Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
  • Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
  • Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
  • Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
  • Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
  • Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.

Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.